Torsten Haferlach

Prof. Torsten Haferlach spent the first part of his career as a medical doctor and hematologist at the university clinics in Kiel and Göttingen, then at the university clinic in Munich (LMU) where he acted as both the senior physician at the Department of Internal Medicine and the Head of the laboratory for leukemia diagnostics.

In 2005, he set up the Munich Leukemia Laboratory (www.mll.com) together with three colleagues from complementary disciplines. Today the lab processes over 140,000 blood or bone marrow samples per year, his practice treats more than 5,000 patients, and more than 840 articles have been published in top ranking, peer‐reviewed medical journals since the lab’s inception.  Dr Haferlach is author or co-author of more than 750 peer-reviewed articles and also co-author of the new WHO Classification 2022.

The Munich Leukemia Laboratory (MLL) has 400 employees and is a central reference laboratory providing diagnostic services for Germany and also for international studies in hematology.  The MLL offers services 7 days a week, including cytomorphology, cytogenetics, FISH, immunophenotyping and molecular genetics, including also WGS and WTS.